Chemoinformaics analysis of (2r,3r,5s,6r)-2,6-Bis(hydroxymethyl)piperidine-3,4,5-triol
Molecular Weight | 193.199 | nRot | 2 |
Heavy Atom Molecular Weight | 178.079 | nRig | 6 |
Exact Molecular Weight | 193.095 | nRing | 1 |
Solubility: LogS | 0.043 | nHRing | 1 |
Solubility: LogP | -2.496 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 15 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 7 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
nHA | 6 | APOL | 26.8019 |
nHD | 6 | BPOL | 15.6181 |
QED | 0.27 |
Synth | 4.115 |
Natural Product Likeliness | 1.836 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.335 |
HIA | 0.914 |
CACO-2 | -5.266 |
MDCK | 0.000532417 |
BBB | 0.212 |
PPB | 0.135026 |
VDSS | 0.367 |
FU | 0.829968 |
CYP1A2-inh | 0.017 |
CYP1A2-sub | 0.039 |
CYP2c19-inh | 0.012 |
CYP2c19-sub | 0.15 |
CYP2c9-inh | 0.001 |
CYP2c9-sub | 0.135 |
CYP2d6-inh | 0.001 |
CYP2d6-sub | 0.127 |
CYP3a4-inh | 0.003 |
CYP3a4-sub | 0.01 |
CL | 1.71 |
T12 | 0.766 |
hERG | 0.047 |
Ames | 0.048 |
ROA | 0.001 |
SkinSen | 0.211 |
Carcinogencity | 0.014 |
EI | 0.127 |
Respiratory | 0.076 |
NR-Aromatase | 0.004 |
Antiviral | No |
Prediction | 0.901489 |